Abstract：A girl, aged 15 months, attended the hospital due to recurrent skin erythema, blisters, and desquamation for more than 7 months. Giemsa staining and immunohistochemical staining showed mast cell infiltration and degranulation. Hematoxylin staining showed spinous layer edema and blister formation under the epidermis, with a large amount of serous fluid and a small number of inflammatory cells in the blister. Marked edema was observed in the dermis, with diffused mononuclear cell infiltration. The girl was diagnosed with mastocytosis. Mastocytosis should be considered for children with recurrent skin erythema and blisters.
LI Ke-Yao,TANG Jian-Ping,LIANG Xiao-Ting et al. Recurrent skin blisters for more than 7 months in a girl aged 15 months[J]. CJCP, 2019, 21(9): 919-923.
Tamay Z, Özçeker D. Current approach to cutaneous mastocytosis in childhood[J]. Turk Pediatri Ars, 2016, 51(3):123-127.
[2]
Carter MC, Metcalfe DD, Komarow HD. Mastocytosis[J]. Immunol Allergy Clin North Am, 2014, 34(1):181-196.
[3]
林元珠, 马琳, 高顺强. 实用儿童皮肤病学[M]. 北京:人民军医出版社, 2016:491.
[4]
Pardanani A. Systemic mastocytosis in adults:2017 update on diagnosis, risk stratification and management[J]. Am J Hematol, 2016, 91(11):1146-1159.
[5]
Kitamura Y, Kanakura Y, Fujita J, et al. Differentiation and transdifferentiation of mast cells:a unique member of the hematopoietic cell family[J]. Int J Cell Cloning, 1987, 5(2):108-121.
[6]
Metcalfe DD. Mast cells and mastocytosis[J]. Blood, 2008, 112(4):946-956.
[7]
Valent P, Arock M, Bonadonna P, et al. European Competence Network on Mastocytosis (ECNM):10-year jubilee, update, and future perspectives[J]. Wien Klin Wochenschr, 2012, 124(23-24):807-814.
[8]
Galli SJ, Tsai M. Mast cells in allergy and infection:versatile effector and regulatory cells in innate and adaptive immunity[J]. Eur J Immunol, 2010, 40(7):1843-1851.
[9]
Azaña JM, Torrelo A, Mediero IG, et al. Urticaria pigmentosa:a review of 67 pediatric cases[J]. Pediatr Dermatol, 1994, 11(2):102-106.
Castells M, Metcalfe DD, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children:practical recommendations[J]. Am J Clin Dermatol, 2011, 12(4):259-270.
[12]
Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis[J]. Immunol Allergy Clin North Am, 2014, 34(2):283-295.
[13]
De la Hoz B, González de Olano D, Alvarez I, et al. Guidelines for the diagnosis, treatment and management of mastocytosis[J]. An Sist Sanit Navar, 2008, 31(1):11-32.
[14]
赵辨. 中国临床皮肤病学(下册)[M]. 南京:江苏科学技术出版社, 2009:1268.
[15]
Escribano L, Akin C, Castells M, et al. Mastocytosis:current concepts in diagnosis and treatment[J]. Ann Hematol, 2002, 81(12):677-690.
[16]
Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis:a consensus proposal[J]. Leuk Res, 2001, 25(7):603-625.
[17]
Valent P, Akin C, Hartmann K, et al. Advances in the classification and treatment of mastocytosis:current status and outlook toward the future[J]. Cancer Res, 2017, 77(6):1261-1270.
[18]
马琳. 儿童皮肤病学[M]. 北京:人民卫生出版社, 2014:342-344.
[19]
Akin C, Valent P. Diagnostic criteria and classification of mastocytosis in 2014[J]. Immunol Allergy Clin North Am, 2014, 34(2):207-218.
[20]
Arock M, Akin C, Hermine O, et al. Current treatment options in patients with mastocytosis:status in 2015 and future perspectives[J]. Eur J Haematol, 2015, 94(6):474-490.
